Hepatitis C - What is Hepatitis C?(NC)-Hepatitis C is an infectious virus that

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Lamivudine does not increase the efficacy of interferon in the

Lamivudine does not increase the efficacy of interferon in the
hbv_research archives Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B.

Lamivudine Journal Data
chronic Viral heaptitis B. Yang SS, Hsu CT, Hu JT, et al. World J Gastroenterol 2002 Oct;8(5):868-71 Abstract Remission of severe aplastic anemia associated

THE CONTRIBUTIONS OF NONHUMAN PRIMATE RESEARCH TO HUMAN HEALTH
Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195.

Hepatitis C - Doctor: Getting the Most from Your Doctor s Appointment

Doctor: Getting the Most from Your Doctor s Appointment
Title: Doctor: Getting the Most from Your Doctor s Appointment
Category: Doctor's Views
Created: 5/13/2005
Last Editorial Review: 5/13/2005
Your Results May Vary For HCV Treatment
According to this study actual treatment results may be only half as good as touted. Doctors tend to trust the numbers presented by the pharaceutical companies. The pharma companies have a vested interest in presenting the best numbers they can...
Primary Biliary Cirrhosis
Title: Primary Biliary Cirrhosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005

Hepatitis C - Hepatitis C Virus Lives In Your Liver(NC)-Your liver works 24

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

Hepatitis C - MedlinePlus: Hepatitis C

MedlinePlus: Hepatitis C
features links to news and articles about HCV infection, its symptoms and diagnosis, treatment options, prevention, alternative therapies, and support organizations.

Advances in treatment of chronic hepatitis C: Pegylated' interferons (PDF)
... drug molecule are an important advance in the. treatment of chronic hepatitis C. ... more than 50% of cases of chronic hepatitis C. In contrast, ...

eMedicine - Hepatitis C : Article by Donald K Strickland, MD
... S, Petris MG, Rossetti F: Chronic hepatitis C virus infection after treatment for ... ribavirin as initial treatment for chronic hepatitis C: Hepatitis Interventional Therapy Group ...

HEPATITIS C
... by a healthcare professional familiar with chronic hepatitis C. Can you have a normal liver enzyme (e.g., ALT) level and still. have chronic hepatitis C? Yes ...

Chronic Hepatitis
Definition - Chronic Hepatitis (CAH) is ongoing injury to the cells of the liver with inflammation which lasts for longer than six months. ... Saharan Africa and among male homosexuals and IV drug users. Chronic hepatitis C behaves differently from hepatitis B ...

Hepatitis C - World J Gastroenterol

World J Gastroenterol
... Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. ...

hbv_research
... of interferon in the treatment of mutant type chronic viral heaptitis B. 23-Oct-2002 Hepatitis C and Hepatitis B Virus ...

Gastroenterology
... Clinicopathological study of viral heaptitis, A. ...

Giornale di malattie infettive e parassitarie on Medscape - 20 12
... of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-hepatitis atrophy of ...

Hepatitis C - Chronic Hepatitis C: Current Disease Management

Chronic Hepatitis C: Current Disease Management
Explains the causes and symptoms of hepatitis C, along with information about diagnosis and treatment.

HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates
for decades before being discovered. According to the CDC, 20 to 30% of people with chronic Hepatitis C will eventually face life-threatening symptoms.

Hepatitis C - Hep C Bulletin

Hep C Bulletin
Almost 4 million Americans have been infected with the Hep C virus. I have been aware of a case that has literally turned the Adult Industry on its head lately about Hepatitis C. I am

Hepatitis C - Gastroenterology

Gastroenterology
... Clinicopathological study of viral heaptitis, A. ...

Hepatitis C - Hepatitis C

Hepatitis C
... Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration ...

Hepatitis C
Hepatitis c - resources for consumers. ... Hepatitis Foundation International. Viral Hepatitis C ...

Hepatitis C - HepHope.com

HepHope.com
... to stay on top of the latest news in the Hep C world. ... C: The BasicsSymptoms of Hep C. Ways Hep C Is SpreadWays Hep C Is ...

HCVets.com
provided by Veterans with hepatitis C to offer information about virus exposure methods during the Vietnam service era.

Hepatitis C - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Vaccination Tames Hepatitis A Infection

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A Infection
Category: Health News
Created: 7/13/2005 1:58:00 AM
Last Editorial Review: 7/13/2005 1:58:14 AM
More HCV Treatment News Coverage
The Los Angeles Times is one of the largest daily newspapers in the US. Their interest in HCV is indicative of a growning awareness of the extent of the disease in this country. The article clearly focuses on the hope...
Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)
Category: Procedures and Tests
Created: 12/31/1997
Last Editorial Review: 8/31/2005
Judge denies new trial in hepatitis C case
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Judge denies new trial in hepatitis C case
Added by mfeed on Dec 01, 2005 10:36 am (GMT -4)

Sioux City Journal - Judge denies new trial in hepatitis C case FREMONT, Neb. ( AP) -- A doctor and nurse accused of infecting 99 patients with hepatitis C will not receive a new trial.Dodge County District Judge John Samson denied a motion filed by attorneys for Dr.... Read more...

Original Bit Published: 01 Dec 05 00:00:00 PST

Hepatitis C - Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Hepatitis C - Hepatitis C Solutions ::: Alternative Hepatitis C treatment

Hepatitis C Solutions ::: Alternative Hepatitis C treatment
Hepatitis C is controllable, Hepatitis C can be beat. Welcome to your Hep C Solution. A recent study showed that 65% of veterans using a San

Hepatitis C: FAQ | CDC Viral Hepatitis
trials (research studies), see www.clinicaltrials.gov . Roche has a Hep C Action Newsletter including details about hepatitis C treatments and services see

Hep C Discussion TOC
Hormones, menopause and Hep C - Yikes! Sharon 7/11/2005 Re: Hormones, menopause and Hep C - Yikes! rlb 7/11/2005 Who Would be Interestd In . Wanda 7/11/2005 Re: Who Would be Interestd

Hep-C
the general population has Hep C, CDoC has done studies that show that 54% of the women and 39% of the men entering prison in California have had an infection with Hep C. The Hep C epidemic has hit

Hepatitis C - Is There A Vaccine For Hepatitis C?(NC)-No, not for hepatitis

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - National HCV Prison Coalition - Hepatitis C Awareness Project

National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection.

HCV Advocate Newsletter
The HCV Advocate newsletter is a valuable resource designed to provide the hepatitis C community with monthly updates on events, clinical research,

Genotyping - HCV News Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and experimental vaccines for Hepatitis C.

HCV Advocate.org
New First Steps with HCV — for the Newly Diagnosed Click on "HCV Advocate" in the top left corner to return to home at any time.

HCV
hepatitis C virus (HCV) was first definitively identified by molecular cloning of The HCV genome consists of a positive-sense RNA molecule approximately

Hepatitis C - HepNet - Hepatitis Update 1:How Significant is Hepatitis C Infection

HepNet - Hepatitis Update 1:How Significant is Hepatitis C Infection
Would you like to see the complete index ? Update 1 - Fall 1995 How significant is hepatitis C infection in Canada? Dr. Sherman is a Hepatologist practicing in Toronto, Canada. This paper has been

"Many Infants Acquire Hepatitis C Infection from Infected Mothers in
Many Infants Acquire Hepatitis C Infection from Infected Mothers in Utero" "Many Infants Acquire Hepatitis C Infection from Infected Mothers in Utero" Women's Health Weekly (09.01.05) Many

hepCuk.info
of the UK National Health Service (NHS), EASL 2004 3. Parkes J. Epidemiology of Hepatitis C infection. Presentation at EASL, April 2005. 4. Health Protection Agency. Hepatitis C laboratory

Hepatitis C - Hepatitis C

Hepatitis C
Title: Hepatitis C
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
Your Results May Vary For HCV Treatment
According to this study actual treatment results may be only half as good as touted. Doctors tend to trust the numbers presented by the pharaceutical companies. The pharma companies have a vested interest in presenting the best numbers they can...
Hepatitis C
Title: Hepatitis C
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
Hepatitis C Caring Ambassadors Program Joins High School Students' Rally on Capi
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Hepatitis C Caring Ambassadors Program Joins High School Students' Rally on Capi
Added by mfeed on Dec 01, 2005 10:36 am (GMT -4)

Market Wire - OREGON CITY, OR -- (MARKET WIRE) -- 12/01/2005 -- At Robinson Secondary School in Fairfax, Virginia, the students in the marketing association (DECA) are working diligently to change of the outcome of the hepatitis C epidemic. ... change of the outcome of the hepatitis C epidemic. In an ongoing effort supported by the Hepatitis C Caring Ambassadors Program (HCCAP), the ...... Read more...

Original Bit Published: 01 Dec 05 00:00:00 PST

Hepatitis C - MIGENIX Inc. (MGI.TO) Second Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification

MIGENIX Inc. (MGI.TO) Second Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification
BioSpace - include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter

Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Com
Canada NewsWire - Results Reported at American Association for the Study of Liver Diseases (AASLD) Meeting Large Phase II Combination Study Under Way SAN FRANCISCO, Nov. representing an area of great unmetmedical need. Chronic hepatitis C affects more than 10 million people inmajor world

MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir
BC Technology - glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis C virus infections the success of treatment for patients suffering from chronic hepatitis C infections

Biolex Therapeutics Announces Initiation of Phase 1 Clinical Study of Hepatitis C Candidate Locteron(TM)
Drug News Wire - for the treatment of patients with chronic hepatitis C. Locteron combines BLX-883, a standard treatment for patients with chronic hepatitis C is pegylated alfa interferon

Hepatitis C - Is There A Vaccine For Hepatitis C?(NC)-No, not for hepatitis

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Hepatitis C - hbv_research

hbv_research
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B 23-Oct-2002 Hepatitis C and Hepatitis B Virus Infection in Different Hemodialysis Units in Belo

World J Gastroenterol
the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002; 8: 868-871 12 Terrault NA. Combined interferon and

USDA Funded Projects
diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample handling on laboratory tests for bovine tuberculosis. The

Hepatitis C - MedlinePlus: Hepatitis C

MedlinePlus: Hepatitis C
features links to news and articles about HCV infection, its symptoms and diagnosis, treatment options, prevention, alternative therapies, and support organizations.

NEJM -- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Original Article from The New England Journal of Medicine -- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C ... Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients: A ... Epidemiology, Diagnosis, and Treatment of Chronic Hepatitis C. Journal of Pharmacy Practice ...

Clinical Trial: Evaluating Silymarin for Chronic Hepatitis C
Evaluating Silymarin for Chronic Hepatitis C. This study is no longer recruiting patients. Information provided by: National Center for Complementary and Alternative Medicine (NCCAM) ClinicalTrials.gov Identifier: NCT00030030. Purpose

Hepatitis C - Hepatitis C - Page 1

Hepatitis C - Page 1
and the development of antibody screening tests, the number of newly acquired acute hepatitis C infection has decreased. In the 1980's, 180,000 cases were identified. At present, this rate has

Hepatitis C - Hep C Woman Bit Man On Ear

Hep C Woman Bit Man On Ear
Daily Record - UKLocalNews 23 November 2005 HEP C WOMAN BIT MAN ON EAR A DRUNK woman who knew she had hepatitis C bit a stranger's ear after he refused to dance with her.Fiona Manson's victim went through six

VX-950 Hep C Protease Inhibitor
National AIDS Treatment Advocacy Project - HW Reesnik reported these data today at AASLD oral session. VX950 Ki=7nM. Dose escalation study. Primary objective: assessment of safety. Secondary objective: assessment of PK and viral kinetics. PART A: 24 healthy subjects.

ViroPharma Hep-C drug promising
Business First of Louisville - ViroPharma Hep-C drug promising said Thursday preliminary results from a phase-I study of its experimental hepatitis C treatment, HCV-796, found the compound demonstrated antiviral effects.

Hepatitis C - MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio

MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio
BioSpace - 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections the success of treatment for patients suffering from chronic hepatitis C infections

XTL Biopharmaceuticals Ltd. (XTL.L) Announces Data Demonstrating The Antiviral Activity Of One Of The Two Anti
BioSpace - presently in Phase Ia clinical trial in patients with chronic hepatitis C. Results from this trial are expected in the

Hepatitis C - Man displaced by fire waits for transplant

Man displaced by fire waits for transplant
OA Online - Levesque, a Vietnam-era Army veteran, has lost his liver to a case of hepatitis C that went undiagnosed for years

Hepatitis C Caring Ambassadors Program Joins High School Students' Rally on Capitol Hill Calling for Passage o
Market Wire - OREGON CITY, OR -- (MARKET WIRE) -- 12/01/2005 -- At Robinson Secondary School in Fairfax, Virginia, the students in the marketing association (DECA) are working diligently to change of the outcome of the hepatitis C epidemic. change of the outcome of the hepatitis C epidemic. In an ongoing effort supported by the Hepatitis C Caring Ambassadors Program (HCCAP), the

Fighting Hepatitis C
US News - million people worldwide have been infected with the Hepatitis C virus that can cause liver failure, cancer, and makeup of people who had hepatitis C to try to find out

TopAbstracts in Hepatitis C 11/29/2005
Doctors Guide - Over 2000 peer-reviewed journals are covered by TopAbstracts. // TopAbstracts in Hepatitis C 11/29/2005 Unregistered User Hepatitis C SEARCH Doctor's Guide The Web

Cambridge biotech develops hepatitis C pill
Boston Herald - It exceeded our expectations. We think this is the most exciting drug possibility out there for all drugs, said Joshua Boger, president and chief executive of Vertex Pharmaceuticals Inc. scientists argue could cure more people with hepatitis C a virus that attacks the liver without the number of Americans infected with hepatitis C has been underestimated by about

Patients with Hepatitis C using more healthcare resources
EurekAlert! - Many patients contracted the disease in the 1970s before testing and safe needle-sharing practices were widespread. As this population ages, experts have predicted an increasing impact on the healthcare system. Patients with Hepatitis C using more healthcare resources Aging patient population burdens healthcare system Use care resources by patients with Hepatitis C has been rising 25 to

Hepatitis C - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate that 240,000

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir

MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir
BC Technology - glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis C virus infections the success of treatment for patients suffering from chronic hepatitis C infections

Biolex Therapeutics begins trial of hepatitis C drug
Pharmaceutical Business Review - Biolex Therapeutics has revealed that the first cohort of subjects in the company's phase I study of investigational hepatitis C candidate, Locteron, have been dosed. initially for the treatment of patients with chronic hepatitis C. Locteron combines BLX-883, a recombinant under development for the treatment of patients with chronic hepatitis C.

Hepatitis C - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - ADA.org: Dental Topics: Hepatitis C Virus (HCV)

ADA.org: Dental Topics: Hepatitis C Virus (HCV)
This page provides current information on the Hepatitis C Virus (HCV) as it relates to dental professionals. ... Americans are infected with hepatitis C virus (HCV) - four times the number infected with human immunodeficiency virus (HIV). Chronic HCV increases the risk of developing serious ...

ViroPharma Announces Data From HCV-086 Proof of Concept Study : ArriveNet Press Releases : Health
ViroPharma Announces Data From HCV-086 Proof of Concept Study EXTON, Pa. , March 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced re ... anti-viral effect of HCV-086 on HCV RNA concentrations in subjects with chronic HCV infection. In each of ...

ViroPharma Announces Advancement of HCV-796 Into Phase 1B Clinical Testing In Hepatitis C Patients
Source: ViroPharma Incorporated. ViroPharma Announces Advancement of HCV-796 Into Phase 1B Clinical Testing In Hepatitis C Patients. EXTON, Pa., ... clinical study in hepatitis C positive patients with HCV-796, a novel antiviral compound that the company is ... division of Wyeth (NYSE:WYE). HCV-796 is a potent orally dosed ...

Hepatitis C - The Hep C Connection (PDF)

The Hep C Connection (PDF)
... The Hep C Connection. Annual Report 2003 ... "The Denver Foundation is a Hep C. Connection funder ...

Delaware County Hep C Connect
Hepatitis Patient Sees Need, Forms Popular Support Group ... Donna Cowan founded the group "Delco Hep C Connect" in Aston, Pennsylvania last fall ... Thank you all who supported Delco Hep C Connect and the 2nd annual liver awareness ride ...

Hep C Aware - ARE YOU?
"Anyone who thinks they are too small to make a difference has never spent the night in a bedroom with a mosquito!" ( anonymous) Watch this year's. Hep C Aware: ... Determined to get the word out about Hep C, she put together shows, toured all over the country ... this mission, Kelly started the Hep C Postcard campaign and began building ...

Hepatitis C - Human Genome Sciences, Inc. (HGSI) Reports Interim Results Of Phase 2 Clinical Trial Of Albuferon(TM) in Combi

Human Genome Sciences, Inc. (HGSI) Reports Interim Results Of Phase 2 Clinical Trial Of Albuferon(TM) in Combi
BioSpace - combination with ribavirin (RBV) in patients with chronic hepatitis C who failed to respond to previous to Prior Interferon Therapy for Chronic Hepatitis C.'(1) The trial is

Schering-Plough Corporation (SGP)'s Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity As Mono
BioSpace - representing an area of great unmet medical need. Chronic hepatitis C affects more than 10 million people in major world

Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Com
Canada NewsWire - Results Reported at American Association for the Study of Liver Diseases (AASLD) Meeting Large Phase II Combination Study Under Way SAN FRANCISCO, Nov. representing an area of great unmetmedical need. Chronic hepatitis C affects more than 10 million people inmajor world

Hepatitis C - How to Choose a Doctor

How to Choose a Doctor
Title: How to Choose a Doctor
Category: Doctor's Views
Created: 6/17/2005
Last Editorial Review: 8/9/2005
Feedster
No Need to Click Here - I'm just claiming my feed at Feedster feedster:888c411b3cd68db1b26fa00bf9faaf81...
Liver Blood Tests
Title: Liver Blood Tests
Category: Procedures and Tests
Created: 6/2/1998
Last Editorial Review: 8/27/2005

Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver